1,847 results on '"Bates, Susan"'
Search Results
2. Lessons from withdrawn accelerated approvals in oncology
3. Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials
4. Early childhood teacher health and wellbeing : rights, risks, and implications
5. 'It is the best job in the world but...' : why EC teachers teach
6. Bilingual children? : or just pre-schoolers learning English?
7. King Solomon and the baby : children’s health in early childhood education
8. Biological and Environmental Research Exascale Requirements Review. An Office of Science review sponsored jointly by Advanced Scientific Computing Research and Biological and Environmental Research, March 28-31, 2016, Rockville, Maryland
9. Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer
10. Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome
11. Malodour classification with low-cost flexible electronics
12. Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer
13. An eye to the future
14. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
15. Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
16. Variants of uncertain significance in precision oncology: nuance or nuisance?
17. Supplemental Table S5 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
18. Figure S3 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
19. Data from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
20. The Impact of Noise in Early Childhood Settings: A New Zealand Perspective
21. The Impact of Exuberance on Equipoise in Oncology Clinical Trials: Sotorasib as Archetype
22. Contribution of neoadjuvant chemotherapy and radiation therapy (intensity-modulated radiation therapy with concurrent chemotherapy versus stereotactic body radiation therapy alone) on tumor volume regression in patients with borderline resectable or locally advanced pancreatic ductal adenocarcinoma: A single institution experience.
23. Abstract PR05: CheMo4METPANC: Combination Chemotherapy (gemcitabine and nab-paclitaxel), chemokine (C-X-C) Motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) in METastatic treatment-naïve PANCreatic adenocarcinoma
24. Mitotane and the myth of 14 mg/L
25. A simple approach to determining the efficacy of antiperspirants using paper-based colorimetric paper sensors: SweatSENSE
26. Role of Tropical Variability in Driving Decadal Shifts in the Southern Hemisphere Summertime Eddy-Driven Jet
27. Dapper doll.
28. Blue-tiful tiles.
29. Atlantic and Pacific tropics connected by mutually interactive decadal-timescale processes
30. Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting
31. The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
32. Literature listing
33. Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials
34. Novel Therapeutic Strategies Exploiting the Unique Properties of Neuroendocrine Neoplasms
35. Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance
36. Contributors
37. Overview of mechanisms of chemoresistance in ovarian cancer
38. Early Childhood Teacher Health and Wellbeing: Rights, Risks, and Implications
39. Assessment of PSA responses and changes in the rate of tumor growth (g-rate)with immune checkpoint inhibitors in US Veterans with prostate cancer
40. Highlights of ASCO 2023
41. Targeting Translation of mRNA as a Therapeutic Strategy in Cancer
42. Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma
43. Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape
44. The influence of complementary practices and spirituality on British design, 1930-2005
45. Literature
46. Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer
47. Abstract CT084: Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following Induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for unresectable locally advanced pancreatic cancer (TIGeR-PaC) - phase III trial interim analysis
48. Data from Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells
49. Supplementary Figures S1-S6 from Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells
50. Data from R-Loop–Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.